HCPCS code lookup
HCPCS Level II
J2353
Injection, octreotide, depot form for intramuscular injection, 1 mg
Ask Rivvi
- Code
- J2353
- Description
- Injection, octreotide, depot form for intramuscular injection, 1 mg
NDC crosswalk
- 00078-0811-81 Sandostatin Lar Depot, Novartis Pharmaceuticals Corporation. Billable units per 11-digit NDC: 10.
- 00078-0818-81 Sandostatin Lar Depot, Novartis Pharmaceuticals Corporation. Billable units per 11-digit NDC: 20.
- 00078-0825-81 Sandostatin Lar Depot, Novartis Pharmaceuticals Corporation. Billable units per 11-digit NDC: 30.
- 00480-9257-08 Octreotide Acetate, Teva Pharmaceuticals USA, Inc.. Billable units per 11-digit NDC: 10.
- 00480-9259-08 Octreotide Acetate, Teva Pharmaceuticals USA, Inc.. Billable units per 11-digit NDC: 20.
- 00480-9262-08 Octreotide Acetate, Teva Pharmaceuticals USA, Inc.. Billable units per 11-digit NDC: 30.
- 67457-0756-10 Octreotide Acetate, Mylan Institutional LLC. Billable units per 11-digit NDC: 10.
- 67457-0759-20 Octreotide Acetate, Mylan Institutional LLC. Billable units per 11-digit NDC: 20.
- 67457-0762-30 Octreotide Acetate, Mylan Institutional LLC. Billable units per 11-digit NDC: 30.
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.